- Home
- » Tags
- » Daiichi Sankyo
Top View
- Daiichi Sankyo Group Value Report 2017
- Partnering Data As of November 2018
- 01 2008 05 パイプライン表(E)A4×2 Final
- Consolidated Financial Results for the Interim Period of Fiscal 2006 (Six-Month Period Ended September 30, 2006)
- Press Release
- News Release
- [Translation] CONVOCATION NOTICE of the 2ND
- Daiichi Sankyo Company, Limited
- 10-Year Financial Summary
- Disclosure Statements
- Daiichi Sankyo Group Value Report 2013
- Forum for Innovative Regenerative Medicine Members
- Daiichi Sankyo Company, Limited
- Gastric Cancer
- Daiichi Sankyo Company, Limited
- (TAS-102) Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy For
- Pharmaceuticals in Japan
- Disclosure Summary
- Press Release
- June 6, 2012 News Release Launch of Pitavastatin Calcium, A
- Reference Datadata (Consolidated(Consolidated Financial Financial Results Results for for FY2008) FY2008)
- November 4, 2009
- Lymphoma: a Single-Arm, Open-Label, Phase 2 Study
- 2017 BIO Asia International Conference Attendee List As of 2/15/2017
- Press Release
- See Appendix(PDF:70KB)
- Senior Executives
- Nissan Chemical Industries, Ltd. CONTENTS
- Press Release
- Taiyo Holdings / 4626
- Notice of the 112Th Ordinary General Meeting of Shareholders
- Daiichi Sankyo Company, Limited
- Rationale and Design of the CANONICAL Study
- Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults
- Developed Asia Pacific Fund
- Ranking of Stocks by Market Capitalization(As of End of Feb.2019)
- TOPIX100 Constituents (As of October 30, 2020) No. Code Issue No. Code Issue 1 1925 DAIWA HOUSE INDUSTRY CO.,LTD
- Convocation Notice of the 4Th Ordinary
- REFERENCE DATA (FY2005 1St Half)
- I Am Committed to Working on Sustainable
- We Will Contribute to the Enrichment of Quality of Life Around the World By
- December 24, 2008 Ajinomoto Co., Inc. Astellas Pharma Inc. NEW INDICATION for FAST-ACTING POSTPRANDIAL HYPOGLICEMIC AGENT FASTI
- Daiichi Sankyo Company, Limited
- Quarterly Portfolio Disclosure Vanguard